Systemic blood pressure and stroke outcome and recurrence

Current Hypertension Reports

Volumn 7, Issue 1, 2005, Pages 72-78

  Hillis, Argye E ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; DANAPAROID; DEXAMPHETAMINE; FIBRINOLYTIC AGENT; FLUDROCORTISONE; GAVESTINEL; HEPARIN; HYPERTENSIVE AGENT; INDAPAMIDE; LABETALOL; MIDODRINE; NICARDIPINE; NIMODIPINE; PERINDOPRIL; PHENYLEPHRINE; PLACEBO; SODIUM CHLORIDE;

BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; LOW DRUG DOSE; META ANALYSIS; NEUROPROTECTION; PROGNOSIS; RECURRENCE RISK; REVIEW; RISK REDUCTION; STROKE; TREATMENT OUTCOME;

EID: 14044270117     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-005-0058-4     Document Type: Review

References (25)

1. Schrader J, Luders S, Kulschewski A, et al.: The ACCESS Study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 2003, 34:1699-1703.
2. Ahmed N, Wahlgren NG: Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Cerebrovasc Dis 2003, 15:235-243.
3. Semplicini A, Maresca A, Boscolo G, et al.: Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch Intern Med 2003, 163: 11-216.
4. Aslanyan S, Fazekas F, Weir CJ, et al.: Blood pressure course during the acute phase of stroke is strongly associated with outcome [abstract]. Stroke 2003, 34:245.
5. Olieviera-Filho J, Silva SC, Trabuco CC, et al.: Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003, 61:1047-1051.
6. Johnston KC, Mayer SA: Blood pressure reduction in ischemic stroke: a two-edged sword? Neurology 2003, 61: 030-1031.
7. Vlcek M, Schillinger M, Lang W, et al.: Association between course of blood pressure within the first 24 hours and functional recovery after acute ischemic stroke. Ann Emerg Med 2003, 42: 19-626.
8. Leonardi-Bee J, Bath PM, Phillips SJ, et al.: Blood pressure and clinical outcomes in the international stroke trial. Stroke 2002, 33:1315-1320.
9. Adams HP, Adams RJ, Brett T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the American Stroke Association. Stroke 2003, 34:1056-1083.
10. Aslanyan S, Fazekas F, Weir CJ, et al.: Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial. Stroke 2003, 34:2420.
11. Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004, 43:18-24.
12. Astrup J, Symon L, Branston NM, Lassen NA: Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977, 8:51-57.
13. Baron JC, Marchal G: Functional imaging in vascular disorders. In Brain Mapping: The Disorders. Edited by Mazziotta JC, Toga AW, Frackowiak RS. San Diego: Academic Press; 2000:299-311.
14. Hillis AE, Wityk RJ, Tuffiash E, et al.: Hypoperfusion of Wernicke's area predicts severity of semantic deficit in acute stroke. Ann Neurol 2001, 50:561-566.
15. Wise G, Sutter R, Burkholder J: The treatment of brain ischemia with vasopressor drugs. Stroke 1972, 3:135-140.
16. Rordorf G, Cramer SC, Efird JT, et al.: Pharmacological elevation of blood pressure in acute stroke. Stroke 1997, 28:2133-2138.
17. Rordorf G, Koroshetz W, Ezzeddine MA, et al.: A pilot study of drug-induced hypertension for treatment of acute stroke Neurology 2001, 56:1210-1213.
18. Hillis AE, Ulatowski JA, Barker PB, et al.: A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003, 16:236-246.
19. Martinsson L, Wahlgren NG: Safety of dexamphetamine in acute ischemic stroke: a randomized, double-blind controlled dose-escalation trial. Stroke 2003, 34:475-481.
20. PROGRESS Collaborative Group: Randomized trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001, 358:1033-1041.
21. Messerli FH, Hanley DF Jr, Gorelick PB: Blood pressure control in stroke patients: What should the consulting neurologist advise?. Neurology 2002, 1:23-25.
22. Chapman N, Huxley R, Anderson C, et al.: Effects of perindopril-based blood pressure lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS trial. Stroke 2004, 35:116-121.
23. Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002, 359:995-1003.
24. Forette F, Seus ML, Staessen JA, et al.: Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) Trial. Lancet 1998, 352: 347-1351.
25. Rothwell PM, Howard SC, Spence JD: Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003, 34:2583-2590.